Cardinal Health (NYSE:CAH) Announces Quarterly Earnings Results

Cardinal Health (NYSE:CAH) posted its earnings results on Wednesday. The company reported $1.84 EPS for the quarter, topping the consensus estimate of $1.74 by $0.10, RTT News reports. Cardinal Health had a net margin of 0.25% and a negative return on equity of 54.74%. The firm had revenue of $59.87 billion during the quarter, compared to analysts’ expectations of $58.74 billion. During the same quarter in the prior year, the firm earned $1.55 EPS. Cardinal Health’s quarterly revenue was up 12.1% on a year-over-year basis. Cardinal Health updated its FY 2025 guidance to 7.550-7.700 EPS and its FY25 guidance to $7.55-7.70 EPS.

Cardinal Health Stock Performance

Shares of NYSE:CAH opened at $109.89 on Friday. The company has a market cap of $26.77 billion, a PE ratio of 48.84, a price-to-earnings-growth ratio of 1.14 and a beta of 0.61. Cardinal Health has a 52 week low of $85.11 and a 52 week high of $116.04. The firm has a 50 day simple moving average of $99.38 and a 200 day simple moving average of $103.23.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, October 15th. Investors of record on Tuesday, October 1st will be paid a dividend of $0.506 per share. The ex-dividend date of this dividend is Tuesday, October 1st. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.02 annualized dividend and a yield of 1.84%. Cardinal Health’s dividend payout ratio is currently 89.78%.

Analyst Ratings Changes

Several research analysts have commented on CAH shares. Morgan Stanley upped their target price on shares of Cardinal Health from $114.00 to $119.00 and gave the stock an “overweight” rating in a research report on Thursday. Evercore ISI upped their target price on shares of Cardinal Health from $105.00 to $115.00 and gave the stock an “in-line” rating in a research report on Thursday. StockNews.com upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Friday. Citigroup decreased their price objective on shares of Cardinal Health from $115.00 to $107.00 and set a “neutral” rating for the company in a report on Friday, July 19th. Finally, Argus decreased their price objective on shares of Cardinal Health from $120.00 to $115.00 and set a “buy” rating for the company in a report on Wednesday, May 15th. One analyst has rated the stock with a sell rating, four have assigned a hold rating, seven have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $117.45.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.